Phospho-specific Antibodies Are Introduced For Diagnosis

Release Date: 24-Sep-2019

Creative diagnosis introduces a newly developed phospho-specific antibodies for global scientists. Creative diagnosis is a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry. This newly developed pospho-specific antibodies can be used for a variety of applications such as immunoprecipitation, immunofluorescence, FACs and ICC.

These high-quality phospho-specific antibodies are available for bulk quantities and can be used for more than 300 phosphoproteins or phosphorylation sites. These antibodies are able to target the protein phosphorylation and they are able to support the science researchers. The new antibodies can reveal the pathology of some human diseases, including neurodegenerative disorders, cardiovascular and cerebrovascular disease, cancers, diabetes, inflammation and endocrine diseases.

Further, phosphotyrosine antibody, which specifically binds to phosphorylated tyrosine residues, is also a valuable tool for analyzing tyrosine kinase activity in high-throughput drug discovery research. Creative Diagnostic’s phospho-specific antibodies have various advantages. It assures its clients with excellent antibodies and related services, which allow scientists to track and quantify phospho proteins using a wide range of techniques.

According to the Jessica Waldrof, chief scientist officer of RandD department of creative diagnosis, Creative Diagnostics have a great group of talented employees dedicated to developing quality antibody products for bio-researchers to accelerate the advancement of science.